These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2569999

  • 1. Acrivastine--an evaluation of initial and peak activity in human skin.
    Marks P, Manna VK, Gibson JR.
    J Int Med Res; 1989; 17 Suppl 2():3B-8B. PubMed ID: 2569999
    [Abstract] [Full Text] [Related]

  • 2. Acrivastine versus terfenadine in the treatment of symptomatic dermographism--a double-blind, placebo-controlled study.
    Boyle J, Marks P, Gibson JR.
    J Int Med Res; 1989; 17 Suppl 2():9B-13B. PubMed ID: 2570004
    [Abstract] [Full Text] [Related]

  • 3. Acrivastine versus hydroxyzine in the treatment of cholinergic urticaria. A placebo-controlled study.
    Kobza Black A, Aboobaker J, Gibson JR, Harvey SG, Marks P.
    Acta Derm Venereol; 1988; 68(6):541-4. PubMed ID: 2467496
    [Abstract] [Full Text] [Related]

  • 4. A comparison of acrivastine versus chlorpheniramine in the treatment of chronic idiopathic urticaria.
    Gale AE, Harvey SG, Calthrop JG, Gibson JR.
    J Int Med Res; 1989; 17 Suppl 2():25B-27B. PubMed ID: 2569998
    [Abstract] [Full Text] [Related]

  • 5. A comparison of acrivastine versus clemastine and placebo in the treatment of patients with chronic idiopathic urticaria.
    Leyh F, Harvey SG, Gibson JR, Manna VK.
    J Int Med Res; 1989; 17 Suppl 2():22B-24B. PubMed ID: 2569997
    [Abstract] [Full Text] [Related]

  • 6. A comparison of acrivastine versus hydroxyzine and placebo in the treatment of chronic idiopathic urticaria.
    Salo OP, Harvey SG, Calthrop JG, Gibson JR.
    J Int Med Res; 1989; 17 Suppl 2():18B-21B. PubMed ID: 2569996
    [Abstract] [Full Text] [Related]

  • 7. Acrivastine: a review of its dermatopharmacology and clinical activity.
    Gibson JR, Manna VK, Salisbury J.
    J Int Med Res; 1989; 17 Suppl 2():28B-34B. PubMed ID: 2475374
    [Abstract] [Full Text] [Related]

  • 8. A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria.
    van Joost T, Blog FB, Westerhof W, Jansen FC, Starink TM, den Boer MS, Kuneman JJ, Harvey SG, Gibson JR.
    J Int Med Res; 1989; 17 Suppl 2():14B-17B. PubMed ID: 2569995
    [Abstract] [Full Text] [Related]

  • 9. An evaluation of the antihistamine activity of acrivastine and its onset in human skin.
    Manna VK, Marks P, Gibson JR.
    J Int Med Res; 1992 Apr; 20(2):106-11. PubMed ID: 1355745
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the new antihistamine acrivastine (BW 825C) versus cyproheptadine in the treatment of idiopathic cold urticaria.
    Neittaanmäki H, Fräki JE, Gibson JR.
    Dermatologica; 1988 Apr; 177(2):98-103. PubMed ID: 2901993
    [Abstract] [Full Text] [Related]

  • 11. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
    Sansom JE, Brooks J, Burton JL, Archer CB.
    Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
    [Abstract] [Full Text] [Related]

  • 12. Effects of acrivastine, loratadine and cetirizine on histamine-induced wheal and flare responses.
    Bayramgürler D, Bilen N, Apaydýn R, Altintaş L, Sal G, Dökmeci S, Utkan T.
    Clin Exp Dermatol; 1999 Sep; 24(5):407-11. PubMed ID: 10564333
    [Abstract] [Full Text] [Related]

  • 13. Prolonged treatment with acrivastine for seasonal allergic rhinitis.
    Bruno G, D'Amato G, Del Giacco GS, Locci F, Gale NM, Errigo E, Melillo G.
    J Int Med Res; 1989 Sep; 17 Suppl 2():40B-46B. PubMed ID: 2570001
    [Abstract] [Full Text] [Related]

  • 14. Time of onset of action of acrivastine in the skin of pollen-allergic subjects. A double-blind, randomized, placebo-controlled comparative study.
    Petersen LJ, Bindslev-Jensen C, Poulsen LK, Malling HJ.
    Allergy; 1994 Jan; 49(1):27-30. PubMed ID: 7911009
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the onset of H1-antagonism with acrivastine and terfenadine by histamine bronchial challenge in volunteers.
    Rolan PE, Adams J, Posner J.
    J Int Med Res; 1989 Jan; 17 Suppl 2():35B-39B. PubMed ID: 2570000
    [Abstract] [Full Text] [Related]

  • 16. French multicentre double-blind study to evaluate the efficacy and safety of acrivastine as compared with terfenadine in seasonal allergic rhinitis.
    Gervais P, Bruttman G, Pedrali P, Charpin J, Michel FB, Grilliat JP.
    J Int Med Res; 1989 Jan; 17 Suppl 2():47B-53B. PubMed ID: 2570002
    [Abstract] [Full Text] [Related]

  • 17. Acrivastine in allergic rhinitis: a review of clinical experience.
    Bojkowski CJ, Gibbs TG, Hellstern KH, Major EW, Mullinger B.
    J Int Med Res; 1989 Jan; 17 Suppl 2():54B-68B. PubMed ID: 2570003
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of histamine or allergen-induced wheals by a single dose of acrivastine, fexofenadine or cetirizine.
    Ballmer-Weber BK, Gex-Collet C, Wüthrich B.
    J Investig Allergol Clin Immunol; 1999 Jan; 9(6):351-5. PubMed ID: 10664928
    [Abstract] [Full Text] [Related]

  • 19. Effects of acrivastine and terfenadine on skin reactivity to histamine.
    Leynadier F, Murrieta M, Dry J, Colin JN, Gillotin C, Steru D.
    Ann Allergy; 1994 Jun; 72(6):520-4. PubMed ID: 7911286
    [Abstract] [Full Text] [Related]

  • 20. Acrivastine. A review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders.
    Brogden RN, McTavish D.
    Drugs; 1991 Jun; 41(6):927-40. PubMed ID: 1715267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.